Using artificial intelligence, a new drug regime has been developed by scientists that can be used to treat diffuse intrinsic pontine glioma, a rare and aggressive form of brain cancer, in children. "In this study, use of AI has identified a drug combination which appears to have promise as a future treatment for some children with incurable brain cancer. It's exciting to think that it could become one of the first examples of a treatment proposed by AI going on to benefit patients," said Kristian Helin, chief executive of The Institute of Cancer Research in London.
Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.